Advisors Capital Management, LLC reports 8.03% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Advisors Capital Management, LLC
Latest Disclosed Ownership	1,010,102 shares
Latest Disclosed Value	$ 61,262,739

On May 1, 2026 - Advisors Capital Management, LLC filed a 13F-HR form disclosing ownership of 1,010,102 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $52,949,547 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 934,995 shares of Bristol-Myers Squibb Company. This represents a change in shares of 8.03% during the quarter. The current value of the position is $47,909,138 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-01	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	1,010,102	75,107	8.03	61,263	21.47	0.7139
2026-01-29	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	934,995	21,015	2.30	50,434	22.35	0.5931
2025-11-07	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	913,980	41,867	4.80	41,221	2.11	0.5104
2025-08-08	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	872,113	59,276	7.29	40,370	-18.57	0.5531
2025-05-27	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	812,837	33,874	4.35	49,575	12.52	0.7671
2025-02-13	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	778,963	83,786	12.05	44,058	125,780.00	0.6930
2024-11-14	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	695,177	520,498	297.97	36	400.00	0.5853
2024-08-09	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	174,679	11,210	6.86	7	-12.50	0.1266
2024-05-06	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	163,469	25,768	18.71	9	14.29	0.1622
2024-02-14	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	137,701	-3,649	-2.58	7	-12.50	0.1438
2023-11-15	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	141,350	6,024	4.45	8	0.00	0.2080
2023-08-03	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	135,326	-60,968	-31.06	9	-38.46	0.2064
2023-05-04	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	196,294	11,253	6.08	14	0.00	0.3525
2023-02-13	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	185,041	2,320	1.27	13	-99.91	0.3617
2022-11-16	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	182,721	16,327	9.81	13,958	8.94	0.3728
2022-08-12	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	166,394	4,328	2.67	12,812	8.25	0.3903
2022-05-10	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	162,066	-3,836	-2.31	11,836	14.42	0.3238
2022-02-14	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	165,902	6,685	4.20	10,344	9.80	0.2806
2021-11-12	2021-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	159,217	1,578	1.00	9,421	-10.56	0.2873
2021-08-02	2021-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	157,639	-201,995	-56.17	10,533	-53.61	0.3339
2021-05-12	2021-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	359,634	7,499	2.13	22,703	3.94	0.7961
2021-02-16	2020-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	352,135	-52,483	-12.97	21,842	-10.47	0.8359
2020-11-05	2020-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	404,618	-29,165	-6.72	24,395	-4.36	1.1377
2020-08-18	2020-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	433,783	-75,333	-14.80	25,506	-10.12	1.2647
2020-05-15	2020-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	509,116	11,245	2.26	28,378	-11.20	1.8011
2020-01-10	2019-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	497,871	22,836	4.81	31,958	32.67	1.4921
2019-11-14	2019-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	475,035	43,180	10.00	24,089	23.00	1.3089
2019-08-15	2019-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	431,855	29,181	7.25	19,585	3.29	1.1639
2019-05-15	2019-03-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	402,674	161,585	67.02	18,962	51.31	1.1811
2019-01-17	2018-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	241,089	-5,253	-2.13	12,532	-18.05	0.9124
2018-10-10	2018-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	246,342	-10,217	-3.98	15,293	7.71	0.9998
2018-08-13	2018-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	256,559	256,559		14,198		0.9774

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.